Journal article
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
American journal of transplantation, v 23(10), pp 1631-1640
Oct 2023
PMID: 37778868
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Respiratory syncytial virus (RSV) is a cause of severe respiratory illness in older adults. In May 2023, the Food and Drug Administration approved the first vaccines for prevention of RSV-associated lower respiratory tract disease in adults aged >= 60 years. Since May 2022, the Advisory Committee on Immunization Practices (ACIP) Respiratory Syncytial Virus Vaccines Adult Work Group met at least monthly to review available evidence regarding the safety, immunogenicity, and efficacy of these vaccines among adults aged >= 60 years. On June 21, 2023, ACIP voted to recommend that adults aged >= 60 years may receive a single dose of an RSV vaccine, using shared clinical decision-making. This report summarizes the body of evidence considered for this recommendation and provides clinical guidance for the use of RSV vaccines in adults aged >= 60 years. RSV vaccines have demonstrated moderate to high efficacy in preventing RSV-associated lower respiratory tract disease and have the potential to prevent substantial morbidity and mortality among older adults; postmarketing surveillance will direct future guidance.
Metrics
Details
- Title
- Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
- Creators
- Michael Melgar - National Center for Immunization and Respiratory DiseasesAmadea Britton - CDC, Coronavirus & Other Resp Viruses Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USALauren E. Roper - National Center for Immunization and Respiratory DiseasesH. Keipp Talbot - Vanderbilt UniversitySarah S. Long - Drexel University, PediatricsCamille N. Kotton - Harvard Medical SchoolFiona P. Havers - CDC, Coronavirus & Other Resp Viruses Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA
- Publication Details
- American journal of transplantation, v 23(10), pp 1631-1640
- Publisher
- ELSEVIER SCIENCE INC; NEW YORK
- Number of pages
- 10
- Grant note
- Veronica V. McNally, Franny Strong Foundation; Katherine A. Poehling, Wake Forest School of Medicine; Pablo J. Syanchez, The Research Institute at Nationwide Children's Hospital.
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Web of Science ID
- WOS:001092828100001
- Scopus ID
- 2-s2.0-85172935495
- Other Identifier
- 991021861294504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Surgery
- Transplantation